MarketPulse

patient enrollment

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

Nektar Therapeutics Faces Class Action Over REZOLVE-AA Trial Misstatements

Nektar Therapeutics faces class action lawsuit alleging securities fraud over alleged REZOLVE-AA trial misstatements involving improper patient enrollment procedures.
NKTRsecurities fraudclass action lawsuit
BenzingaBenzinga··Business Wire

Nektar Therapeutics Faces Securities Fraud Lawsuit Over Misleading Trial Claims

Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.
NKTRsecurities fraudclass action lawsuit